Recent Blog Articles

Harvard Health Blog

Beyond CBD: Here come the other cannabinoids, but where’s the evidence?

GettyImages-1178042601-1-scaled
Published: March 23, 2021

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Comments

David Ostrow
March 23, 2021

Very helpful and balanced description of some of the rare “minor” Cannabinoids present in hemp and cannabis. While I prefer complex full spectrum extracts and concentrates that maximize the “Entourage effects,” I agree with Dr Grinspoon that we need more scientific research to understand the therapeutic uses and possible adverse SEs of these compounds now that we have the ability to produce them in sufficient quantities. But for the testing of whole plant-derived Cannabinoid formulations for conditions like pain and opioid misuse, I invite Dr Grinspoon and other medical cannabis specialists to join the CBCCERN-AMNet Project collaboration that is currently recuiting clinician investigators for practice-based Community-Based Clinical Cannabis Research and Evaluation (the CBCCERN).

Commenting has been closed for this post.

You might also be interested in…

Medical Marijuana: Facts about cannabis, THC, and CBD

Exploring medical cannabis means becoming a highly educated consumer. You need to learn as much as you can from a variety of sources. This guide is intended to help you make a more-informed decision. This guide can’t tell you whether medical cannabis will alleviate your health conditions or symptoms. But it will provide basic information to help you consider whether medical cannabis is right for you, ideally working openly with your physician and other health care providers.

Read More